Article
SGLT2 inhibitors, GLP-1 RAs are effective, but costly in T2D
- Author:
- Randy Dotinga
Publish date: July 10, 2019
News
Polyester. Plywood. Pizza. Skin allergens lurk in unusual places
- Author:
- Randy Dotinga
Publish date: July 10, 2019
News

Acne in women: What new insights tell us
- Author:
- Randy Dotinga
Publish date: July 9, 2019
News
Metformin linked to lower dementia risk in black patients
- Author:
- Randy Dotinga
Publish date: July 8, 2019
News
SGLT2 inhibitors for type 1 diabetes: Doctors debate the merits
- Author:
- Randy Dotinga
Publish date: July 3, 2019
News

New findings cast more doubt on ‘fat-but-fit’ theory
- Author:
- Randy Dotinga
Publish date: July 1, 2019
News

To help patients stay on diabetes regimens: Communicate, educate, and use technology
- Author:
- Randy Dotinga
Publish date: July 1, 2019
News

Surprise! High-fat dairy may protect against metabolic syndrome
- Author:
- Randy Dotinga
Publish date: June 29, 2019
News

Do black patients with type 2 diabetes gain cardiac benefit from the SGLT2 and GLP-1 drugs?
- Author:
- Randy Dotinga
Publish date: June 25, 2019
News

Children with Down syndrome may need more screening for sleep-disordered breathing
- Author:
- Randy Dotinga
Publish date: June 22, 2019
News

Aggressive lowering of LDL cholesterol: Is it a good idea?
- Author:
- Randy Dotinga
Publish date: June 20, 2019
News

Three out of five ain’t bad? Some diabetes measures improved over 17 years
- Author:
- Randy Dotinga
Publish date: June 14, 2019
News

In MS, the challenges for women are unique
- Author:
- Randy Dotinga
Publish date: June 13, 2019
News

Breast cancer linked to 23% higher risk for new diabetes
- Author:
- Randy Dotinga
Publish date: June 13, 2019
News

In MS, children aren’t just little adults
- Author:
- Randy Dotinga
Publish date: June 13, 2019
